Trial Profile
Clinical Trials Insight: 700036933
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2008
Price :
$35
*
At a glance
- Drugs IMO 2134 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Novartis
- 09 Sep 2008 New trial record.